{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:26:59Z","timestamp":1793921219684,"version":"4.8.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["R33-CA202820"],"award-info":[{"award-number":["R33-CA202820"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA14051"],"award-info":[{"award-number":["P30CA14051"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["K08CA222663"],"award-info":[{"award-number":["K08CA222663"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","award":["n\/A"],"award-info":[{"award-number":["n\/A"]}],"id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1038\/s41591-020-0926-0","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T16:03:58Z","timestamp":1592841838000},"page":"1271-1279","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":469,"title":["A single-cell landscape of high-grade serous ovarian cancer"],"prefix":"10.1038","volume":"26","author":[{"given":"Benjamin","family":"Izar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5477-2987","authenticated-orcid":false,"given":"Itay","family":"Tirosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6578-3216","authenticated-orcid":false,"given":"Elizabeth H.","family":"Stover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5248-4823","authenticated-orcid":false,"given":"Isaac","family":"Wakiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2163-5120","authenticated-orcid":false,"given":"Michael S.","family":"Cuoco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idan","family":"Alter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Rodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Leeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Ju","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parin","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8375-8447","authenticated-orcid":false,"given":"Marcin","family":"Iwanicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay","family":"Kanodia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes C.","family":"Melms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaolin","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4702-7705","authenticated-orcid":false,"given":"Jia-Ren","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline B. M.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Slyper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Waldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livnat","family":"Jerby-Arnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orr","family":"Ashenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Titus J.","family":"Brinker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2608-4084","authenticated-orcid":false,"given":"Caitlin","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meri","family":"Rogava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Vigneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3364-1838","authenticated-orcid":false,"given":"Peter K.","family":"Sorger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levi A.","family":"Garraway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1032-1479","authenticated-orcid":false,"given":"Panagiotis A.","family":"Konstantinopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce F.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Matulonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce E.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6313-3570","authenticated-orcid":false,"given":"Orit","family":"Rozenblatt-Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asaf","family":"Rotem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3293-3158","authenticated-orcid":false,"given":"Aviv","family":"Regev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,22]]},"reference":[{"key":"926_CR1","doi-asserted-by":"crossref","first-page":"16061","DOI":"10.1038\/nrdp.2016.61","volume":"2","author":"UA Matulonis","year":"2016","unstructured":"Matulonis, U. A. et al. Ovarian cancer. Nat. Rev. Dis. Primers 2, 16061 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"926_CR2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"Cancer Genome Atlas Research Network","year":"2011","unstructured":"Cancer Genome Atlas Research Network Integrated genomic analyses of ovarian carcinoma. Nature 474, 609\u2013615 (2011).","journal-title":"Nature"},{"key":"926_CR3","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ygyno.2017.01.015","volume":"144","author":"BJ Winterhoff","year":"2017","unstructured":"Winterhoff, B. J. et al. Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells. Gynecol. Oncol. 144, 598\u2013606 (2017).","journal-title":"Gynecol. Oncol."},{"key":"926_CR4","doi-asserted-by":"crossref","first-page":"e0206785","DOI":"10.1371\/journal.pone.0206785","volume":"13","author":"AJ Shih","year":"2018","unstructured":"Shih, A. J. et al. Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq. PLoS ONE 13, e0206785 (2018).","journal-title":"PLoS ONE"},{"key":"926_CR5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ccell.2020.01.003","volume":"37","author":"Z Hu","year":"2020","unstructured":"Hu, Z. et al. The repertoire of serous ovarian cancer non-genetic heterogeneity revealed by single-cell sequencing of normal fallopian tube epithelial cells. Cancer Cell 37, 226\u2013242.e7 (2020).","journal-title":"Cancer Cell"},{"key":"926_CR6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2016. CA Cancer J. Clin. 66, 7\u201330 (2016).","journal-title":"CA Cancer J. Clin."},{"key":"926_CR7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nature14410","volume":"521","author":"A-M Patch","year":"2015","unstructured":"Patch, A.-M. et al. Whole-genome characterization of chemoresistant ovarian cancer. Nature 521, 489\u2013494 (2015).","journal-title":"Nature"},{"key":"926_CR8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fonc.2013.00256","volume":"3","author":"N Ahmed","year":"2013","unstructured":"Ahmed, N. & Stenvers, K. L. Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research. Front. Oncol. 3, 256 (2013).","journal-title":"Front. Oncol."},{"key":"926_CR9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189\u2013196 (2016).","journal-title":"Science"},{"key":"926_CR10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nature20123","volume":"539","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I. et al. Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma. Nature 539, 309\u2013313 (2016).","journal-title":"Nature"},{"key":"926_CR11","doi-asserted-by":"crossref","first-page":"eaai8478","DOI":"10.1126\/science.aai8478","volume":"355","author":"AS Venteicher","year":"2017","unstructured":"Venteicher, A. S. et al. Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq. Science 355, eaai8478 (2017).","journal-title":"Science"},{"key":"926_CR12","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","volume":"171","author":"SV Puram","year":"2017","unstructured":"Puram, S. V. et al. Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell 171, 1611\u20131624.e24 (2017).","journal-title":"Cell"},{"key":"926_CR13","doi-asserted-by":"crossref","first-page":"28.8.1","DOI":"10.1002\/cpmb.26","volume":"116","author":"B Izar","year":"2016","unstructured":"Izar, B. & Rotem, A. GILA, a replacement for the soft-agar assay that permits high-throughput drug and genetic screens for cellular transformation. Curr. Protoc. Mol. Biol. 116, 28.8.1\u201328.8.12 (2016).","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"926_CR14","doi-asserted-by":"crossref","first-page":"E4978","DOI":"10.1073\/pnas.1315370110","volume":"110","author":"VM Peterson","year":"2013","unstructured":"Peterson, V. M. et al. Ascites analysis by a microfluidic chip allows tumor-cell profiling. Proc. Natl Acad. Sci. USA 110, E4978\u2013E4986 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"926_CR15","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nmeth.2639","volume":"10","author":"S Picelli","year":"2013","unstructured":"Picelli, S. et al. Smart-seq2 for sensitive full-length transcriptome profiling in single cells. Nat. Methods 10, 1096\u20131098 (2013).","journal-title":"Nat. Methods"},{"key":"926_CR16","doi-asserted-by":"crossref","first-page":"4.22.1","DOI":"10.1002\/0471142727.mb0422s107","volume":"107","author":"JJ Trombetta","year":"2014","unstructured":"Trombetta, J. J. et al. Preparation of single-cell RNA-seq libraries for next generation sequencing. Curr. Protoc. Mol. Biol. 107, 4.22.1\u20134.22.17 (2014).","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"926_CR17","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41591-020-0844-1","volume":"26","author":"M Slyper","year":"2020","unstructured":"Slyper, M. et al. A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors. Nat. Med. 26, 792\u2013802 (2020).","journal-title":"Nat. Med."},{"key":"926_CR18","first-page":"482","volume":"1","author":"P Cirri","year":"2011","unstructured":"Cirri, P. & Chiarugi, P. Cancer associated fibroblasts: the dark side of the coin. Am. J. Cancer Res. 1, 482\u2013497 (2011).","journal-title":"Am. J. Cancer Res."},{"key":"926_CR19","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","volume":"214","author":"D \u00d6hlund","year":"2017","unstructured":"\u00d6hlund, D. et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J. Exp. Med. 214, 579\u2013596 (2017).","journal-title":"J. Exp. Med."},{"key":"926_CR20","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2009.10.014","volume":"139","author":"D Iliopoulos","year":"2009","unstructured":"Iliopoulos, D., Hirsch, H. A. & Struhl, K. An epigenetic switch involving NF-\u03baB, Lin28, let-7 microRNA, and IL6 links inflammation to cell transformation. Cell 139, 693\u2013706 (2009).","journal-title":"Cell"},{"key":"926_CR21","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9971","volume":"6","author":"D Aran","year":"2015","unstructured":"Aran, D., Sirota, M. & Butte, A. J. Systematic pan-cancer analysis of tumour purity. Nat. Commun. 6, 8971 (2015).","journal-title":"Nat. Commun."},{"key":"926_CR22","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1158\/0008-5472.CAN-10-3175","volume":"71","author":"IA Silva","year":"2011","unstructured":"Silva, I. A. et al. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Cancer Res. 71, 3991\u20134001 (2011).","journal-title":"Cancer Res."},{"key":"926_CR23","doi-asserted-by":"crossref","first-page":"9546","DOI":"10.18632\/oncotarget.2542","volume":"5","author":"X Wu","year":"2014","unstructured":"Wu, X. et al. AXL kinase as a novel target for cancer therapy. Oncotarget 5, 9546\u20139563 (2014).","journal-title":"Oncotarget"},{"key":"926_CR24","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.cell.2018.10.008","volume":"175","author":"M Biton","year":"2018","unstructured":"Biton, M. et al. T helper cell cytokines modulate intestinal stem cell renewal and differentiation. Cell 175, 1307\u20131320.e22 (2018).","journal-title":"Cell"},{"key":"926_CR25","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2019.06.029","volume":"178","author":"CS Smillie","year":"2019","unstructured":"Smillie, C. S. et al. Intra- and inter-cellular rewiring of the human colon during ulcerative colitis. Cell 178, 714\u2013730.e22 (2019).","journal-title":"Cell"},{"key":"926_CR26","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.cell.2019.03.025","volume":"177","author":"Y Miao","year":"2019","unstructured":"Miao, Y. et al. Adaptive immune resistance emerges from tumor-initiating stem cells. Cell 177, 1172\u20131186.e14 (2019).","journal-title":"Cell"},{"key":"926_CR27","doi-asserted-by":"crossref","first-page":"eaar3342","DOI":"10.1126\/scitranslmed.aar3342","volume":"10","author":"SJ Rodig","year":"2018","unstructured":"Rodig, S. J. et al. MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma. Sci. Transl. Med. 10, eaar3342 (2018).","journal-title":"Sci. Transl. Med."},{"key":"926_CR28","first-page":"1263","volume":"23","author":"JF Liu","year":"2016","unstructured":"Liu, J. F. et al. Establishment of patient-derived tumor xenograft models of epithelial ovarian cancer for preclinical evaluation of novel therapeutics. Clin. Cancer Res. 23, 1263\u20131273 (2016).","journal-title":"Clin. Cancer Res."},{"key":"926_CR29","first-page":"1270","volume":"63","author":"MA Blaskovich","year":"2003","unstructured":"Blaskovich, M. A. et al. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase\/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res. 63, 1270\u20131279 (2003).","journal-title":"Cancer Res."},{"key":"926_CR30","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina, J. et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603\u2013607 (2012).","journal-title":"Nature"},{"key":"926_CR31","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1158\/0008-5472.CAN-12-3542","volume":"73","author":"EM Dijkgraaf","year":"2013","unstructured":"Dijkgraaf, E. M. et al. Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironment. Cancer Res. 73, 2480\u20132492 (2013).","journal-title":"Cancer Res."},{"key":"926_CR32","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1158\/1078-0432.CCR-18-3200","volume":"25","author":"ML Axelrod","year":"2019","unstructured":"Axelrod, M. L., Cook, R. S., Johnson, D. B. & Balko, J. M. Biological consequences of MHC-II expression by tumor cells in cancer. Clin. Cancer Res. 25, 2392\u20132402 (2019).","journal-title":"Clin. Cancer Res."},{"key":"926_CR33","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cell.2017.07.025","volume":"170","author":"A Jim\u00e9nez-S\u00e1nchez","year":"2017","unstructured":"Jim\u00e9nez-S\u00e1nchez, A. et al. Heterogeneous tumor-immune microenvironments among differentially growing metastases in an ovarian cancer patient. Cell 170, 927\u2013938.e20 (2017).","journal-title":"Cell"},{"key":"926_CR34","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.cell.2018.03.073","volume":"173","author":"AW Zhang","year":"2018","unstructured":"Zhang, A. W. et al. Interfaces of malignant and immunologic clonal dynamics in ovarian cancer. Cell 173, 1755\u20131769.e22 (2018).","journal-title":"Cell"},{"key":"926_CR35","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.1158\/1078-0432.CCR-06-0861","volume":"12","author":"Z Duan","year":"2006","unstructured":"Duan, Z. et al. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer. Clin. Cancer Res. 12, 5055\u20135063 (2006).","journal-title":"Clin. Cancer Res."},{"key":"926_CR36","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1158\/1078-0432.CCR-16-2196","volume":"23","author":"S Kommoss","year":"2017","unstructured":"Kommoss, S. et al. Bevacizumab may differentially improve ovarian cancer outcome in patients with proliferative and mesenchymal molecular subtypes. Clin. Cancer Res. 23, 3794\u20133801 (2017).","journal-title":"Clin. Cancer Res."},{"key":"926_CR37","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ng.3225","volume":"47","author":"A Calon","year":"2015","unstructured":"Calon, A. et al. Stromal gene expression defines poor-prognosis subtypes in colorectal cancer. Nat. Genet. 47, 320\u2013329 (2015).","journal-title":"Nat. Genet."},{"key":"926_CR38","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/annonc\/mdw168","volume":"27","author":"JM Pitt","year":"2016","unstructured":"Pitt, J. M. et al. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy. Ann. Oncol. 27, 1482\u20131492 (2016).","journal-title":"Ann. Oncol."},{"key":"926_CR39","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nbt.2203","volume":"30","author":"SL Carter","year":"2012","unstructured":"Carter, S. L. et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30, 413\u2013421 (2012).","journal-title":"Nat. Biotechnol."},{"key":"926_CR40","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1073\/pnas.1505979112","volume":"112","author":"A Rotem","year":"2015","unstructured":"Rotem, A. et al. Alternative to the soft-agar assay that permits high-throughput drug and genetic screens for cellular transformation. Proc. Natl Acad. Sci. USA 112, 5708\u20135713 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"926_CR41","first-page":"6011","volume":"46","author":"AF Gazdar","year":"1986","unstructured":"Gazdar, A. F. & Oie, H. K. Re: growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. Cancer Res. 46, 6011\u20136012 (1986).","journal-title":"Cancer Res."},{"key":"926_CR42","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1172\/JCI69815","volume":"124","author":"RA Davidowitz","year":"2014","unstructured":"Davidowitz, R. A. et al. Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance. J. Clin. Invest. 124, 2611\u20132625 (2014).","journal-title":"J. Clin. Invest."},{"key":"926_CR43","doi-asserted-by":"crossref","first-page":"e86829","DOI":"10.1172\/jci.insight.86829","volume":"1","author":"MP Iwanicki","year":"2016","unstructured":"Iwanicki, M. P. et al. Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition. JCI Insight 1, e86829 (2016).","journal-title":"JCI Insight"},{"key":"926_CR44","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1182\/blood-2007-12-129718","volume":"112","author":"EA Nelson","year":"2008","unstructured":"Nelson, E. A. et al. Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3. Blood 112, 5095\u20135102 (2008).","journal-title":"Blood"},{"key":"926_CR45","doi-asserted-by":"crossref","first-page":"e31657","DOI":"10.7554\/eLife.31657","volume":"7","author":"J-R Lin","year":"2018","unstructured":"Lin, J.-R. et al. Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes. eLife 7, e31657 (2018).","journal-title":"eLife"},{"key":"926_CR46","volume":"12","author":"B Li","year":"2011","unstructured":"Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12, 323 (2011).","journal-title":"BMC Bioinformatics"},{"key":"926_CR47","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel, A. P. et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344, 1396\u20131401 (2014).","journal-title":"Science"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41591-020-0926-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41591-020-0926-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41591-020-0926-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:03:23Z","timestamp":1684620203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-020-0926-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,22]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["926"],"URL":"https:\/\/doi.org\/10.1038\/s41591-020-0926-0","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,22]]},"assertion":[{"value":"1 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.I. is a consultant for Merck and Volastra Therapeutics. L.A.G. is an employee of Genentech. L.A.G. was previously an employee of Eli Lilly. L.A.G. was a paid consultant for Novartis, Foundation Medicine and Boehringer Ingelheim, held equity in Foundation Medicine and was a recipient of a grant from Novartis. P.K.S. is a member of the SAB or Board of Directors and holds equity in Applied Biomath, Glencoe Software and RareCyte. A.Rotem is a consultant to eGenesis, a member of the SAB in NucleAI and an holds equity in Celsius. A.Regev is a SAB member of Thermo Fisher Scientific, Neogene Therapeutics, Asimov and Syros Pharmaceuticals, a cofounder of and equity holder in Celsius Therapeutics, and an equity holder in Immunitas Therapeutics. B.I., I.T., E.H.S., L.A.G., O.R.-R., A.Rotem and A.Regev have filed a provisional patent for the use of JSI-124 for the treatment of ovarian cancer. The other authors have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}